Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 21, 2022
Carisma Therapeutics
|
Series C | $30M | Biotechnology | — |
Mar 1, 2021
Carisma Therapeutics
|
Series B | $12M | Biotechnology | — |
Jun 27, 2018
Carisma Therapeutics
|
Series A | $53M | Biotechnology | — |